Safety of long-term biologic therapy in rheumatologic patients with a previously resolved hepatitis B viral infection.
about
Hepatitis B virus reactivation associated with antirheumatic therapy: Risk and prophylaxis recommendationsHepatitis B Virus Reactivation in the Setting of Cancer Chemotherapy and Other Immunosuppressive Drug Therapy.Admissions for hepatitis B reactivation in patients receiving immunosuppressive therapy remain unchanged from 1999 to 2014.Risk of Hepatitis B Reactivation in Inflammatory Arthritis Patients Receiving Disease Modifying Anti-Rheumatic Drugs (DMARDs): a Systematic Review and Meta-analysis.Reactivation of occult hepatitis B virus infection in patients with rheumatic diseases: pathogenesis, risk assessment and prevention.Reactivation of hepatitis B virus during targeted therapies for cancer and immune-mediated disorders.Infectious complications of rituximab therapy in renal disease.Nationwide prospective and retrospective surveys for hepatitis B virus reactivation during immunosuppressive therapies.Prevention of HBV reactivation in patients treated with biologic agents.Tumor necrosis factor inhibitor therapy for hepatitis B virus-infected individuals: How loud is the alarm bell?Update on Prevention, Diagnosis, and Treatment and of Chronic Hepatitis B: AASLD 2018 Hepatitis B Guidance.Hepatitis B virus reactivation in HBsAg-negative, anti-HBc-positive patients receiving immunosuppressive therapy: a systematic review.
P2860
Q26784247-48AEC7B3-A24F-4B06-947E-CDED4BF782C8Q36958944-BDF418CE-8803-43B6-A868-E54527C6EF10Q38566383-BFA06332-6FC6-461D-9B9F-308A94BAD155Q38611674-01705E70-8339-402D-AE35-00105189B4FDQ38634826-462242E0-7408-47FC-B4B9-4684161207B6Q38810735-5DAB82BA-FACA-421B-BF07-CA981ECE399FQ40065728-1A8BF89D-5E52-4A04-BC58-DDFDF7366F98Q40810286-7AA50192-A6A8-40EB-AFFC-D2AF436020CDQ40830395-DB16DFA0-5B01-4E92-BC78-34C89BD4F268Q44736299-A4F9AC9F-36D2-4C3D-8AD6-383E1FAEF3AFQ50190669-CD9F4FBE-2BD4-4532-8123-FD01FB68A5ECQ55487854-3229349E-F8E9-46C7-BA2B-8B2447D5E4A3
P2860
Safety of long-term biologic therapy in rheumatologic patients with a previously resolved hepatitis B viral infection.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Safety of long-term biologic t ...... d hepatitis B viral infection.
@en
type
label
Safety of long-term biologic t ...... d hepatitis B viral infection.
@en
prefLabel
Safety of long-term biologic t ...... d hepatitis B viral infection.
@en
P2093
P2860
P50
P356
P1433
P1476
Safety of long-term biologic t ...... ed hepatitis B viral infection
@en
P2093
Antonella Notarnicola
Francesco Sebastiani
Michele Covelli
P2860
P356
10.1002/HEP.27716
P407
P50
P577
2015-02-24T00:00:00Z